More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Q: I am a 74-year-old female and was diagnosed with popliteal artery stenosis in my left calf. When walking briskly, it is ...

Does it sometimes feel like your supper is sitting like a boulder in your gut? You may have a condition called gastroparesis. About 1 in 4 people have symptoms of the disorder, which causes the ...

Eye-stroke, vomiting and burst colon: Lawsuits accuse weight-loss drugs of severe side effects - Thousands of patients have ...

In a podcast episode of The Diary Of A CEO, insulin resistance expert Dr Benjamin Bikman explains how the blockbuster GLP-1 ...

The class of drugs known as GLP-1 receptor agonists have become renowned for their effects in helping weight loss.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Chances are—you or someone you know—is taking a GLP-1 to lose weight. The popular medications are sold under names like Ozempic, Wegovy, Zepbound and Mounjaro. In a week-long series, WRTV Investigates ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...